Abstract:One of the main challenges in drug discovery is to find molecules that bind specifically and strongly to their target protein while having minimal binding to other proteins. By predicting binding affinity, it is possible to identify the most promising candidates from a large pool of potential compounds, reducing the number of compounds that need to be tested experimentally. Recently, deep learning methods have shown superior performance than traditional computational methods for making accurate predictions on large datasets. However, the complexity and time-consuming nature of these methods have limited their usage and development. Quantum machine learning is an emerging technology that has the potential to improve many classical machine learning algorithms. In this work we present a hybrid quantum-classical convolutional neural network, which is able to reduce by 20% the complexity of the classical network while maintaining optimal performance in the predictions. Additionally, it results in a significant time savings of up to 40% in the training process, which means a meaningful speed up of the drug discovery process.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficiency and accuracy of predicting the binding affinity between molecules and proteins. Specifically, the researchers face the following challenges: 1. **A Key Issue in Drug Discovery**: Find molecules that can bind specifically and strongly to their target proteins while minimizing binding to other proteins. By predicting binding affinity, the most promising candidates can be screened from a large number of potential compounds, reducing the number of compounds that need to be experimentally tested. 2. **Limitations of Existing Methods**: Although deep - learning methods perform better than traditional computational methods when dealing with large data sets, their complexity and time - consuming nature limit the use and development of these methods. 3. **The Potential of Quantum Machine Learning**: Quantum machine learning is an emerging technology with the potential to improve classical machine - learning algorithms. The paper proposes a Hybrid Quantum - Classical Convolutional Neural Network (HQ - CNN), aiming to reduce the complexity of the classical network while maintaining prediction performance and significantly shortening the training time. ### Specific Contributions of the Paper - **Reducing Complexity**: By replacing the first convolutional layer with a quantum circuit, HQ - CNN can reduce 20% of the training parameters, thereby reducing the complexity of the model. - **Improving Training Efficiency**: Compared with the classical CNN, the training time of HQ - CNN is reduced by 20 - 40%, which means a significant speed increase in the drug discovery process. - **Design of Quantum Circuits**: The paper describes in detail how to use the Flexible Representation of Quantum Images (FRQI) method to encode data and designs a Random Quantum Circuit (Quantum Reservoir, QR) to extract features. - **Error Mitigation**: To address the noise problem of current quantum devices, the paper proposes a Data Regression Error Mitigation (DRER) algorithm to reduce the noise in the output of quantum circuits. ### Conclusion The paper demonstrates the advantages of HQ - CNN in reducing model complexity and improving training efficiency, providing new tools and methods for future drug discovery. By combining quantum computing and classical machine learning, researchers are expected to accelerate the drug development process and improve the accuracy and efficiency of prediction.

Hybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions

Binding affinity predictions with hybrid quantum-classical convolutional neural networks

A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery

Prediction of Protein-Ligand Binding Affinity by a Hybrid Quantum-Classical Deep Learning Algorithm

Atomic Convolutional Networks for Predicting Protein-Ligand Binding Affinity

A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design

Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery

Quantum Machine Learning for Drug Discovery

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Synergistic Application of Molecular Docking and Machine Learning for Improved Binding Pose

Hybrid Quantum Neural Network for Drug Response Prediction

Hybrid Quantum Graph Neural Network for Molecular Property Prediction

QPowered Compound2DeNovoDrugPropMax –A Novel Programmatic Tool Incorporating Deep Learning and In Silico Methods for Automated In Silico Bio- Activity Discovery for any Compound of Interest

Prediction of drug protein interactions based on variable scale characteristic pyramid convolution network

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Data-driven quantum chemical property prediction leveraging 3D conformations with Uni-Mol

Quantum to Classical Neural Network Transfer Learning Applied to Drug Toxicity Prediction

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing

Application of Quantum Tensor Networks for Protein Classification

Drug–target binding affinity prediction based on three-branched multiscale convolutional neural networks

Quantum-Inspired Machine Learning for Molecular Docking